Transcriptional activation by AP-2α is modulated by the oncogene DEK

Nucleic Acids Research

Volumn 31, Issue 5, 2003, Pages 1571-1575

  Campillos, Mónica ^a   García, Miguel Angel ^a   Valdivieso, Fernando ^a   Vázquez, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TRANSCRIPTION FACTOR AP 2;

AFFINITY CHROMATOGRAPHY; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL TYPE; CONTROLLED STUDY; DNA BINDING; EMBRYO DEVELOPMENT; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNODETECTION; IN VITRO STUDY; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; REVIEW; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VERTEBRATE;

APOLIPOPROTEINS E; CHROMATOGRAPHY, AFFINITY; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; ONCOGENE PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

VERTEBRATA;

EID: 0037336622     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg247     Document Type: Review

References (42)

1. Williams,T., Admon,A., Luscher,B. and Tjian,R. (1988) Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev., 2, 1557-1569.
2. Mitchell,P.J., Wang,C. and Tjian,R. (1987) Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell, 50, 847-861.
3. Moser,M., Imhof,A., Pscherer,A., Bauer,R., Amselgruber,W., Sinowatz,F., Hofstadter,F., Schule,R. and Buettner,R. (1995) Cloning and characterization of a second AP-2 transcription factor: AP-2β. Development, 121, 2779-2788.
4. Oulad-Abdelghani,M., Bouillet,P., Chazaud,C., Dolle,P. and Chambon,P. (1996) AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. Exp. Cell Res., 225, 338-347.
5. Zhao,F., Satoda,M., Licht,J.D., Hayashizaki,Y. and Gelb,B.D. (2001) Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2δ, with unique DNA binding and transactivation properties. J. Biol. Chem., 276, 40755-40760.
6. Mitchell,P.J., Timmons,P.M., Hebert,J.M., Rigby,P.W. and Tjian,R. (1991) Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev., 5, 105-119.
7. Chazaud,C., Oulad-Abdelghani,M., Bouillet,P., Decimo,D., Chambon,P. and Dolle,P. (1996) AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech. Dev., 54, 83-94.
8. Moser,M., Ruschoff,J. and Buettner,R. (1997) Comparative analysis of AP-2α and AP-2β gene expression during murine embryogenesis. Dev. Dyn., 208, 115-124.
9. Schorle,H., Meier,P., Buchert,M., Jaenisch,R. and Mitchell,P.J. (1996) Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature, 381, 235-238.
10. Zhang,J., Hagopian-Donaldson,S., Serbedzija,G., Elsemore,J., Plehn-Dujowich,D., Mcmahon,A.P., Flavell,R.A. and Williams,T. (1996) Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature, 381, 238-241.
11. Moser,M., Pscherer,A, Roth,C., Becker,J., Mucher,G., Zerres,K., Dixkens,C., Weis,J., Guay-Woodford,L., Buettner,R. and Fassler,R. (1997) Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β. Genes Dev., 11, 1938-1948.
12. Byrne,C., Tainsky,M. and Fuchs,E. (1994) Programming gene expression in developing epidermis. Development, 120, 2369-2383.
13. Eilers,M., Schirm,S. and Bishop,J.M. (1991) The MYC protein activates transcription of the α-prothymosin gene. EMBO J., 10, 133-141.
14. Batsche,E., Muchardt,C., Behrens,J., Hurst,H.C. and Cremisi,C. (1998) RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol. Cell. Biol., 18, 3647-3658.
15. Wu,F. and Lee,A.S. (1998) Identification of AP-2 as an interactive target of Rb and a regulator of the G1/S control element of the hamster histone H3.2 promoter. Nucleic Acids Res., 26, 4837-4845.
16. WU,F. and Lee,A.S. (2001) YY1 as a regulator of replication-dependent hamster histone H3.2 promoter and an interactive partner of AP-2. J. Biol. Chem., 276, 28-34.
17. Mertens,P.R., Alfonso-Jaume,M.A., Steinmann,K. and Lovett,D.H. (1998) A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J. Biol. Chem., 273, 32957-32965.
18. Pena,P., Reutens,A.T., Albanese,C., D'amico,M., Watanabe,G., Donner,A., Shu,I.W., Williams,T. and Pestell,R.G. (1999) Activator Protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA. Mol. Endocrinol., 13, 1402-1416.
19. Artiga,M.J., Bullido,M.J., Sastre,I., Recuero,M., García,M.A., Aldudo,J., Vázquez,J. and Valdivieso,F. (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett., 421, 105-108.
20. Artiga,M.J., Bullido,M.J., Frank,A., Sastre,I., Recuero,M., García,M.A., Lendon,C.L., Han,S.W., Morris,J.C., Vázquez,J., Goate,A. and Valdivieso,F. (1998) Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum. Mol. Genet., 7, 1887-1892.
21. Bullido,M.J., Artiga,M.J., Recuero,M., Sastre,I., García,M.A., Aldudo,J., Lendon,C., Han,S.W., Morris,J.C., Frank,A., Vázquez,J., Goate,A. and Valdivieso,F. (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nature Genet., 18, 69-71.
22. García,M.A., Vázquez,J., Giménez,C., Valdivieso,F. and Zafra,F. (1996) Transcription factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells. J. Neurosci., 16, 7550-7556.
23. García,M.A., Campillos,M., Marina,A., Valdivieso,F. and Vázquez,J. (1999) Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation. FEBS Lett., 444, 27-31.
24. Andrews,N.C. and Faller,D.V. (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res., 19, 2499.
25. Zabala,M.T. and García-Ruiz,J.P. (1989) Regulation of expression of the messenger ribonucleic acid encoding the cytosolic form of phosphoenolpyruvate carboxykinase in liver and small intestine of lactating rats. Endocrinology, 125, 2587-2593.
26. Von Lindern,M., Fornerod,M., Van Baal,S., Jaegle,M., De Wit,T., Buijs,A. and Grosveld,G. (1992) The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol. Cell. Biol., 12, 1687-1697.
27. Kannan,P. and Tainsky,M.A. (1999) Coactivator PC4 mediates AP-2 transcriptional activity and suppresses ras-induced transformation dependent on AP-2 transcriptional interference. Mol. Cell. Biol., 19, 899-908.
28. Bosher,J.M., Williams,T. and Hurst,H.C. (1995) The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl Acad. Sci. USA, 92, 744-747.
29. García,M.A., Campillos,M., Ogueta,S., Valdivieso,F. and Vázquez,J. (2000) Identification of amino acid residues of transcription factor AP-2 involved in DNA binding. J. Mol. Biol., 301, 807-816.
30. Fu,G.K., Grosveld,G. and Markovitz,D.M. (1997) DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer. Proc. Natl Acad. Sci. USA, 94, 1811-1815.
31. Aravind,L. and Koonin,E.V. (2000) SAP-a putative DNA-binding motif involved in chromosomal organization. Trends Biochem. Sci., 25, 112-114.
32. Wu,L., Wu,H., Ma,L., Sangiorgi,F., Wu,N., Bell,J.R., Lyons,G.E. and Maxson,R. (1997) Miz1, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech. Dev., 65, 3-17.
33. Fornerod,M., Boer,J., Van Baal,S., Jaegle,M., Von Lindern,M., Murti,K.G., Davis,D., Bonten,J., Buijs,A. and Grosveld,G. (1995) Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene, 10, 1739-1748.
34. Faulkner,N.E., Hilfinger,J.M. and Markovitz,D.M. (2001) Protein phosphatase 2A activates the HIV-2 promoter through enhancer elements that include the pets site. J. Biol. Chem., 276, 25804-25812.
35. Alexiadis,V., Waldmann,T., Andersen,J., Mann,M., Knippers,R. and Gruss,C. (2000) The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes Dev., 14, 1308-1312.
36. Barbaric,S., Munsterkotter,M., Goding,C. and Horz,W. (1998) Cooperative Pho2-Pho4 interactions at the PHO5 promoter are critical for binding of Pho4 to UASp1 and for efficient transactivation by Pho4 at UASp2. Mol. Cell. Biol., 18, 2629-2639.
37. Grueneberg,D.A., Natesan,S., Alexandre,C. and Gilman,M.Z. (1992) Human and Drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor. Science, 257, 1089-1095.
38. Wankhade,S., Yu,Y., Weinberg,J., Tainsky,M.A. and Kannan,P. (2000) Characterization of the activation domains of AP-2 family transcription factors. J. Biol. Chem., 275, 29701-29708.
39. Bamforth,S.D., Braganca,J., Eloranta,J.J., Murdoch,J.N., Marques,F.I., Kranc,K.R., Farza,H., Henderson,D.J., Hurst,H.C. and Bhattacharya,S. (2001) Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nature Genet., 29, 469-474.
40. Kannan,P., Yu,Y., Wankhade,S. and Tainsky,M.A. (1999) PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic Acids Res., 27, 866-874.
41. Meyn,M.S., Lu-Kuo,J.M. and Herzing,L.B. (1993) Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxia-telangiectasia group D fibroblasts. Am. J. Hum. Genet., 53, 1206-1216.
42. Kondoh,N., Wakatsuki,T., Ryo,A., Hada,A., Aihara,T., Horiuchi,S., Goseki,N., Matsubara,O., Takenaka,K., Shichita,M., Tanaka,K., Shuda,M. and Yamamoto,M. (1999) Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res., 59, 4990-4996.